 Erytech Pharma SA NASDAQ: ERYP has sold its US manufacturing facility to Catalent Inc NYSE: CTLT for 44.5 million. Catalent will acquire Erytechs commercial-scale cell therapy manufacturing facility in Princeton, New Jersey, with 40 people. 